Search

everythinglearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

New treatment improves male hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

KGF and activin are crucial for skin healing and repair.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Fat tissue stem cells may help increase hair growth.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Alopecia areata involves immune response and gene changes affecting hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.